Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
MCHR1 antagonist 4
Cat. No.:
OB0425LY-224
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
MCHR1 antagonist 4 is a compound that specifically inhibits melanocortin receptor 1 (MCHR1) and has effects on the regulation of appetite and energy metabolism.
Synonyms:
1574538-43-4; MCHR1 antagonist 4; MCHR-1 antagonist 4
CAS No.:
1574538-43-4
Formula:
C26H30N2O4
Formula Weight:
434.53
Specification
Target:
MCHR1 (GPR24)
Pathway:
GPCR/G protein; Neuronal signaling
Storage:
Storage at -20°C.
Applications:
MCHR1 antagonist 4 is primarily used to study drug development for diseases related to obesity and appetite regulation, as well as to evaluate its potential therapeutic effects in metabolic syndrome.
